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2312 | Analyst, 2014, 139, 2312–2317Live-cell vibrational imaging of choline metabolites
by stimulated Raman scattering coupled with
isotope-based metabolic labeling†
Fanghao Hu,a Lu Wei,a Chaogu Zheng,b Yihui Shena and Wei Min*acCholine is a small molecule that occupies a key position in the
biochemistry of all living organisms. Recent studies have strongly
implicated choline metabolites in cancer, atherosclerosis and nervous
system development. To detect choline and its metabolites, existing
physical methods such as magnetic resonance spectroscopy and
positron emission tomography are often limited by the poor spatial
resolution and substantial radiation dose. Fluorescence imaging,
although with submicrometer resolution, requires introduction of
bulky ﬂuorophores and thus is diﬃcult in labeling the small choline
molecule. By combining the emerging bond-selective stimulated
Raman scattering microscopy with metabolic incorporation of
deuterated choline, herein we have achieved high resolution
imaging of choline-containing metabolites in living mammalian cell
lines, primary hippocampal neurons and the multicellular organism
C. elegans. Diﬀerent subcellular distributions of choline metabolites
are observed between cancer cells and non-cancer cells, which may
reveal a functional diﬀerence in the choline metabolism and lipid-
mediated signaling events. In neurons, choline incorporation is visu-
alized within both soma and neurites, where choline metabolites are
more evenly distributed compared to proteins. Furthermore, choline
localization is also observed in the pharynx region of C. elegans larvae,
consistent with its organogenesis mechanism. These applications
demonstrate the potential of isotope-based stimulated Raman scat-
tering microscopy for future choline-related disease detection and
development monitoring in vivo.Introduction
Choline metabolism performs critical roles in biological func-
tion of all living organisms. It is involved in various vital
processes such as cell membrane formation, signaling,sity, 3000 Broadway, New York, NY, USA.
ia University, New York, NY, USA
University, New York, NY, USA
(ESI) available: Details of materials,
.1039/c3an02281alipid transport, neurotransmitter acetylcholine synthesis
and methyl transfer reaction.1 Important choline-containing
metabolites include small molecule phosphocholine (PC),
glycerophosphocholine (GPC), lipid-bound phosphatidylcho-
line (PtC) and sphingomyelin (SM).
Choline metabolites have been discovered to be important in
oncogenesis,2 cardiovascular disease,3 and embryonic nervous
system development.1 Recently, abnormal choline metabolism
has emerged as a metabolic hallmark in cancer malignant
transformation. The diﬀusive choline-containing metabolite
level (including free choline, PC and GPC) has been found to be
2–20 fold higher in tumor compared to normal tissues, partic-
ularly in breast, brain and prostate cancers.2 The elevated level
of choline metabolites in cancer has not only been attributed to
the fast cell proliferation rate, but also indicated the aggres-
siveness of tumor development.4–6 In addition, the development
of atherosclerosis has been associated with choline and its
metabolites, the level of which can be used to predict the risk of
cardiovascular disease.3 Furthermore, as an essential nutrient
for higher organisms including humans, suﬃcient uptake of
choline through diet is required for the maintenance of health.1
Especially during pregnancy and lactation, the highest amount
of choline-containing compounds is present in the utero and
fetus plasma, indicating the crucial role of choline in embryonic
development.7 It has been found that rodents supplemented
with 0.5 wt% choline diet during latter days of gestation when
the memory center begins to develop produce oﬀspring with
life-long enhanced memory and hippocampal plasticity,8 and
choline deciency in pregnant rodents results in altered blood
vessel formation in fetal mouse hippocampus,9 impaired
sensory inhibition10 and cognitive decits.11
Therefore, the ability to monitor choline and its metabolites
during diseases and embryogenesis will be highly desired.
Conventionally, choline metabolites have been studied by 1H
and 31P magnetic resonance spectroscopy (MRS), positron
emission tomography (PET) using 11C-choline12 and liquid
chromatography tandem mass spectrometry (LC-MS).3,13
Current MRS and PET techniques, however, are hindered by theThis journal is © The Royal Society of Chemistry 2014
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View Article Onlinepoor spatial resolution and signicant radiation exposure, and
mass spectrometry cannot achieve non-destructive imaging.
Optical microscopy, with its superior spatial-temporal resolu-
tion and noninvasive nature, shows great advantages in
biochemical imaging at the subcellular level.14 In particular,
uorescence microscopy is one of the most widely used optical
imaging techniques. However, the requirement of a large
conjugation system for light absorption in the visible range
limits its utility in detecting small molecules, which can be
easily perturbed by the attachment of bulky uorophores. An
indirect labeling approach, such as bioorthogonal tagging
through click chemistry, has been developed recently to allow
the study of a wide range of small molecules.15,16 Unfortunately,
this technique generally requires non-physiological cell xation
and the use of toxic catalysts for dye staining, and thus it is
not compatible with live cell imaging. Hence, direct visualiza-
tion of small choline-containing molecules through vibrational
contrasts of either intrinsic or exogenous chemical bonds
becomes a promising approach.
Here we report non-invasive in vivo imaging of choline-con-
taining metabolites with subcellular resolution by stimulated
Raman scattering (SRS) microscopy (Fig. 1a), through metabolic
incorporation of deuterated (trimethyl-D9)-choline. Once taken
up by cells, choline is mainly metabolized through the Kennedy
pathway into small molecules PC, GPC and membrane-bound
choline phospholipids (Fig. 1b). Activated choline metabolism in
tumor and high consumption of choline during prenatal devel-
opment will lead to active uptake of D9-choline incorporatedFig. 1 Stimulated Raman scattering (SRS) imaging of choline metab-
olites through metabolic incorporation of deuterated D9-choline. (a)
Set up of an SRS microscope. Spatially and temporally overlapped
Stokes and pump beams lead to selective vibrational activation within
the sample under the resonant conditions. (b) Incorporation of D9-
choline in the cellular pool of choline metabolites serves as a meta-
bolic biomarker in tumor progression, brain function and embryonic
development. (c) Energy diagram together with the input and output
laser spectra of SRS.
This journal is © The Royal Society of Chemistry 2014into the total pool of choline metabolites in a dynamic equilib-
rium, which serves as a distinct biomarker for cancer, neural
function and embryonic development.
As an emerging nonlinear vibrational imaging technique,
SRS microscopy has achieved high resolution chemical imaging
in many biological systems with excellent sensitivity.17–22 By
employing an additional near-infrared Stokes beam, vibrational
transition which matches with the energy diﬀerence DE
between the pump and Stokes photons is selectively stimulated
(Fig. 1c) via quantum amplication with an eﬀective Raman
cross-section 107 greater than that of spontaneous Raman
scattering.23 The accompanied stimulated Raman loss (SRL)
signal of the transmitted pump beam or the stimulated Raman
gain (SRG) signal of the transmitted Stokes beam can be
detected sensitively by a high-frequency modulation scheme
through a lock-in amplier. Thus, high-speed imaging up to the
video rate can be achieved, which is several orders of magnitude
faster than spontaneous Raman imaging. Compared with
another popular nonlinear Raman technique, coherent anti-
Stokes Raman scattering (CARS), the SRS signal has little
non-resonant background, well preserved Raman spectra,
straightforward image interpretation and linear concentration
dependence, allowing for unambiguous image visualization
and quantication based on pure chemical contrast.24 When
coupled with the strategy of stable isotope labeling, high-reso-
lution SRS imaging of choline metabolites in several mamma-
lian cell lines, primary neurons, and the multicellular organism
C. elegans will be demonstrated in this study.
Results and discussion
With all methyl groups of choline substituted with deuterium
atoms, D9-choline-containing metabolites can be detected
inside cells with high sensitivity and specicity in a back-
ground-free manner. First, characteristic C–D vibrational peaks
around 2100 cm1 arise in the cell-silent Raman window
ranging from 1900 to 2700 cm1 (Fig. 2), where ve major peaksFig. 2 Spontaneous Raman spectra of HeLa cells supplemented with
(black) and without (blue) D9-choline and 100 mM D9-choline (red) in
phosphate buﬀered saline (PBS) solution. The 2188 cm1 peak within
the cell-silent Raman region is chosen for SRS imaging.
Analyst, 2014, 139, 2312–2317 | 2313
Fig. 3 SRS images of D9-choline-containing metabolites in diﬀerent
cancer (a–c) and embryonic (d–e) cell lines. (a) 2188 cm1 image of
D9-choline metabolites (choline-on) in live HeLa cells cultured with 10
mM D9-choline for 48 hours. A strong signal is seen at regions around
the nucleus (indicated by arrows), such as endoplasmic reticulum. (b)
2188 cm1 choline-on image in live HeLa cells cultured in medium
without D9-choline. (c–e) 2188 cm
1 choline-on images in live human
bone osteosarcoma U2OS cells (c), live human embryonic kidney
HEK293T cells (d), and live mouse embryonic ﬁbroblast NIH3T3 cells
(e) cultured with 5 or 10 mM D9-choline for 48 hours. The 1655 cm
1
(amide I from protein) and the 1900 cm1 (choline-oﬀ) images display
the same set of cells as in the choline-on images. The choline-on and
choline-oﬀ channels are imaged under identical experimental condi-
tions. The color scale in the amide channel is 3 times larger than those
in other channels. The color bars in the choline channels correspond
to a D9-choline concentration range from 0 at the darkest to 78.7 mM
at the brightest. Scale bar: 10 mm.
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View Article Onlineare observed at 2089, 2118, 2141, 2188 and 2285 cm1. Second,
the methyl C–D stretching frequencies are expected to be
sensitive to the chemical environment. Local environmental
sensitivity of the vibrational frequency has been well investi-
gated, with nitrile and carbonyl groups being successfully used
as vibrational probes for local electric elds inside proteins.25–27
When compared with Raman spectra of D3-methionine and D10-
leucine (Fig. S1†), even though they all have CD3 groups, C–D
bonds of D9-choline vibrate at frequencies distinct from the
other two molecules, partly due to the positive charge on the
nearby nitrogen atom. This allows for selective imaging of
molecules only containing the trimethyl-D9 moiety derived from
D9-choline. Such spectral selectivity is especially benecial since
choline methyl groups could be transferred to methionine,
which acts as a common methyl source in cells. Third, other
forms of C–D vibration are negligible, because methyl groups of
choline stay mostly intact along its metabolic pathways, as in
both the Kennedy pathway and methyl-transfer pathway. The
2188 cm1 peak of D9-choline is thus chosen for our SRS
imaging due to its highest intensity and clear separation in the
spectrum. Fourth, with a nearly indistinguishable structure to
the natural choline and minimal biochemical perturbation to
cells, D9-choline coupled with SRS is particularly suitable for in
vivo imaging of choline metabolites during diseases and
embryonic development.
Live cell imaging of D9-choline metabolites is rst demon-
strated with SRS in the human cervical cancer HeLa cell line.
Indeed, the spontaneous Raman spectrum of HeLa cells sup-
plemented with 10 mM D9-choline for 48 hours exhibits the
same pattern of Raman peaks in the cell-silent region as for
D9-choline in PBS solution (Fig. 2), verifying the cellular uptake
of D9-choline. Based on the Raman intensity (Fig. 2, black
and red spectra), average intracellular D9-choline-containing
metabolites are estimated to be 20 mM aer 48 hour incor-
poration. We also correlated the SRS intensity at 2188 cm1 with
D9-choline PBS solutions at diﬀerent concentrations (Fig. S2†).
This corresponds to a concentration range from 0 to 78.7 mM
for the color bars of D9-choline images. The SRS image (Fig. 3a)
of the amide channel at 1655 cm1 shows a high protein
concentration outside the nucleus and in the nucleoli. When
tuning into 2188 cm1, the choline-on SRS image depicts the
total pool of D9-choline-containing metabolites including free
choline, PC, GPC, phospholipid-bound choline PtC and SM.
The choline signal distributes over the whole cell and is espe-
cially pronounced in regions surrounding the nucleus, likely
from the endoplasmic reticulum and Golgi apparatus. This
observation is consistent with the intracellular choline meta-
bolic pathway, where choline phospholipid metabolites are
synthesized both in cytosol and on the surface of the nucleus
and intracellular organelles, and are incorporated into the
membrane structure aerwards.28,29 In the choline-oﬀ SRS
image taken at 1900 cm1, where no Raman transition occurs,
an almost completely dark image is acquired, conrming the
background-free detection of SRS microscopy. In the control
HeLa cells cultured without D9-choline (Fig. 3b), no signal is
detected in both the choline-on and choline-oﬀ channels
under the same image acquisition conditions, proving that the2314 | Analyst, 2014, 139, 2312–2317signal observed in Fig. 3a is indeed from the metabolite pool
containing D9-choline.
To verify the enrichment of D9-choline into the total choline
metabolite pool, particularly the downstream choline phos-
pholipids, we subjected the immobile part of the SRS choline
signal retained aer xation to phospholipase assays. In xed
cells incubated with phospholipase C, choline phosphate
headgroups are cleaved from phospholipids under Ca2+ catal-
ysis and little signal can be observed in the choline-on channel,
similar to the choline-oﬀ channel (Fig. S3b†), whereas the signal
mostly remains when no phospholipase is present (Fig. S3a†) orThis journal is © The Royal Society of Chemistry 2014
Fig. 4 SRS imaging of D9-choline metabolites in primary mouse
hippocampal neurons. (a) Spontaneous Raman spectrum of a neuron
cultured with 10 mM D9-choline for 48 hours. (b) 2188 cm
1 choline-
on image clearly reveals the distribution of D9-choline-containing
metabolites within the neural network. (c) Zoomed in image of a single
neuron shows the subcellular distribution of D9-choline metabolites.
The amide images display the same set of cells as in the choline-on
images. The color scale in the amide channel is 2 times larger than
those in other channels. The color bars in the choline channels
correspond to a D9-choline concentration range from 0 at the darkest
to 78.7 mM at the brightest. Scale bar: 10 mm.
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View Article OnlineEDTA is added to chelate the Ca2+ ion (Fig. S3c†). This conrms
the incorporation of D9-choline in the downstream phospho-
lipids PtC and SM, and therefore the total pool of choline
metabolites. Compared with a previously reported method
to image membrane choline phospholipids through bio-
orthogonal uorescent labeling,30 the direct SRS imaging here is
free from cell xation, dye-staining and extensive washing. Thus
our approach not only is compatible with live cell imaging but
also avoids the loss of the important diﬀusive choline-con-
taining species and membrane surface phospholipids during
the xation and staining processes, thus providing a compre-
hensive and accurate picture of choline-containing metabolites
inside cells.
Motivated by the importance of choline metabolism in both
oncogenesis and embryonic development, we then studied the
D9-choline incorporation (as well as their possible diﬀerence) in
other cancer and embryonic cell lines. In the human bone
osteosarcoma U2OS cell line (Fig. 3c), cells incubated with
10 mM D9-choline for 48 hours again show a strong D9-choline
metabolite signal around the nucleus while proteins in the
amide channel is distributed more homogeneously in the whole
cell. The signal in the choline-on channel is similar to that in
the HeLa cells (Fig. 3a). The choline-oﬀ channel is still mostly
dark as expected. Depending on the cell morphology and
orientation, some residual signal exists at the boundaries of the
membrane and lipid droplets, due to the cross-phase modula-
tion of laser beams at the interface of diﬀerent refractive
indices.31 To gain insight into embryonic development, choline
metabolites in human embryonic kidney cells HEK293T
(Fig. 3d) and mouse embryonic broblast cells NIH3T3 (Fig. 3e)
were also imaged. While proteins are similarly distributed
throughout the cell and enriched inside the nucleoli, indicating
active ribosomal biogenesis,32,33 SRS signals of choline-con-
taining metabolites from both embryonic cells are mostly
detected in the cytoplasm with a nearly vanishing signal inside
the nucleus. Such a signicant diﬀerence in the intranuclear
signal between cancer cells (HeLa and U2OS) and non-cancer
cells (HEK293T and NIT3T3) suggests an elevated choline
metabolite level inside the nucleus of cancer cells, possibly due
to an up-regulated choline metabolism that leads to altered
endonuclear lipid-mediated signaling events in cancer.34 This is
hard to visualize by click-chemistry based uorescence imaging
due to low nuclear permeability of uorophores and the loss of
small molecules during xation.
To demonstrate the general applicability of our approach in
the neuronal system, we cultured primary mouse hippocampal
neurons with 10 mM D9-choline for 48 hours. In the sponta-
neous Raman spectrum (Fig. 4a), a similar D9-choline spectral
pattern was observed with higher intensity (approximately a
factor of two) than that in HeLa cells, which conrms the
successful uptake of D9-choline into neurons and is in agree-
ment with the high content of lipids in neuronal cells. In the
SRS images (Fig. 4b), the amide channel at 1655 cm1 depicts
the total protein distribution, which is concentrated inside the
cell body with a much brighter signal than that at the neurites,
whereas in the choline-on channel at 2188 cm1, the network
between neurons is clearly visible with a less pronouncedThis journal is © The Royal Society of Chemistry 2014diﬀerence in the D9-choline metabolite signal between the
neurites and the soma. Since choline phospholipid metabolism
occurs mainly inside the cell body, at the surface of the nucleus
and endoplasmic reticulum,28 the detected D9-choline signal at
the neurites indicates newly assembled membranes with
D9-choline incorporated PtC and SM which are transported
from the soma. When zoomed in, the subcellular distribution of
D9-choline metabolites can be visualized within a single neuron
(Fig. 4c). In the amide channel, proteins are distributed
throughout the cell body and the nucleolus is visible with a
higher protein signal, while choline metabolites are mainly
outside the nucleus.
To further study the role of choline in embryonic develop-
ment, we used Caenorhabditis elegans to visualize choline
incorporation during embryonic and early larval development.
This animal is widely used as a model organism in develop-
mental biology, particularly for embryogenesis and organo-
genesis. 100 mM D9-choline PBS solution was microinjected
into the gonad of wild-type young adult animals and newly
hatched larvae were collected aer one day for live imaging. We
expected the diﬀusive D9-choline, which could be taken up byAnalyst, 2014, 139, 2312–2317 | 2315
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View Article Onlinethe oocyte of adult worms as nutrients before the fertilization,
to be metabolized and incorporated during the embryogenesis
of C. elegans. As control, an untreated C. elegans larva, the
progeny of the uninjected adult worm, was rst imaged
(Fig. 5a), where a dark background was observed in the choline-
on channel at 2188 cm1. The L1 larva produced by the adult
worm injected with D9-choline, however, showed a signicant
signal at the pharynx region in the choline-on channel, mainly
around the terminal bulb (Fig. 5b). Interestingly, the distribu-
tion of this choline signal is similar to the pattern shown in
the lipid CH2 channel at 2845 cm
1, which is located in theFig. 5 SRS imaging of D9-choline incorporation in C. elegans larvae.
(a) As control, a live wild-type C. elegans larva without any treatment
was imaged and a dark background was found in the 2188 cm1
choline-on image. (b) 100 mMD9-choline was injected into the gonad
of young adult animals and the live F1 larva was imaged at L1 stage. The
2188 cm1 choline-on channel displays a similar signal pattern to the
lipid CH2 channel at 2845 cm
1, suggesting the localization of D9-
choline in the cell membrane. The amide, lipid CH2 and the choline-oﬀ
channels display the same area as in the choline-on channel. The color
scale in the amide channel is 6 times larger than those in the choline
channels. The color bars in the choline channels correspond to a
D9-choline concentration range from 0 at the darkest to 78.7 mM at
the brightest. Scale bar: 5 mm.
2316 | Analyst, 2014, 139, 2312–2317periphery of the cells with dark regions inside, indicating the
incorporation of D9-choline into cell membrane structures. The
choline-oﬀ channel is mostly clear with a residual cross-phase
modulation signal seen at the body surface of the worm. Our
observation is consistent with the pharynx organogenesis
process in the C. elegans embryo, where pharynx develops
through autonomous morphogenesis with only cell diﬀerenti-
ation but not cell division,35 avoiding the dilution of D9-choline.
The distribution of the protein signal in the amide channel, on
the other hand, is more homogeneous throughout the whole
worm body with less dened cellular structures, in contrast to
that in both the lipid CH2 and choline-on channels.
Conclusions
In this article, we have successfully demonstrated live cell
imaging of the choline-containing metabolite pool (including
free choline, PC, GPC, PtC and SM) in several cancer, embryonic
cell lines, primary neurons and C. elegans larvae with subcel-
lular resolution, by using stimulated Raman scattering coupled
with isotope-labeled metabolic incorporation. Cancer cells were
found to have a signicant distribution of choline metabolites
inside the nucleus compared to non-cancer cells, which could
inuence endonuclear lipid-mediated signaling events. Choline
incorporation in both the cell body and neuronal processes
has been visualized in hippocampal neurons, where choline
metabolites are more evenly distributed than proteins. In
C. elegans larvae, choline-containing metabolites were localized
in the pharynx region, which is consistent with their autono-
mous organogenesis process.
The ability to image choline metabolites in live cells and
organisms with high resolution, as shown in this study, will
prepare us to better study cancer malignant transformation
and embryonic development in complex systems. Recently,
D9-choline has been used as a metabolic tracer in humans.36
With the excellent biocompatibility of stable isotope incorpo-
ration32 and SRS microscopy in living animals and humans,37
our approach of isotope-based nonlinear vibrational imaging
would nd future applications in choline-related disease diag-
nostics and treatment evaluation in vivo.
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